Scheme details
Area: Newcastle upon Tyne, Sunderland, County Durham, Gateshead, South Tyneside, North Tyneside, Northumberland
Categories: Finance & funding, Business support
Business stage: Trading business
Page last updated: 20 March 2024
Delivered by Innovate UK, this engaging programme consists of a Get ready preparation phase, 5-day innovation visit to focus on Singapore, an exploitation workshop, and support from an Innovate UK innovation and growth specialist - helping your business to identify opportunities and develop innovation projects with partners in the country.
Focus Areas:
Applications are welcomed from innovative MedTech & Diagnostics companies that focus on but not limited to:
- Medical Technologies
- Diagnostics including but not limited to In Vitro Diagnostics (IVDs)
- Medical Imaging
- Wearables
Areas of Focus that are not being considered are:
- Patient Management Software
- Digital Health
- Formulated Therapeutics (* therapeutic delivery devices may be considered)
Why Singapore?
Singapore’s Research, Innovation and Enterprise 2025 Plan aims to better transform and protect health, advance human potential & create economic value for Singapore. Priorities include transforming and protecting health through (i) shifting the focus towards both health promotion & disease prevention as the population ages (ii) supporting the health system to become more data-driven and patient-centric to deliver value-based care through the innovative use of both technology and digital solutions at scale (iii) using data analytics to support public health actions & telemedicine to deliver quality care to the wider population and (iv) expanding the national precision medicine research programme. A further priority is maximising economic value by growing a vibrant mix of start-ups and scale-ups with a strong translational ecosystem, with a particular focus on biotech companies.
With the Asia-Pacific Medical Technology (MedTech) market expected to grow to US$225 billion by 2030, Singapore is strategically placed to enable companies to tap into these regional opportunities, and Singapore’s network of top universities, research institutions and innovative start-ups also enable MedTech companies to fully engage with a vibrant open innovation ecosystem.
Singapore has an advanced digital economy and is consistently ranked as one of the world’s most innovative cities. Building on the strong mutual interest in co-innovation between Singapore and the UK, Enterprise Singapore and Innovate UK will be opening the latest round of their bilateral R&D grant funding call, coinciding with the timing of this GBIP visit to Singapore.
Key dates
Applicant Briefing: 25 March 2024 Register here
Closing date for applications: 21 April 2024
Pre-visit briefing(s): 20 & 21 May 2024
Innovation visit: 1 – 5 July 2024
Post-visit workshop: September 2024